✦ LIBER ✦

Is the door open again for neuroprotection trials in stroke?

✍ Scribed by Markku Kaste

Book ID: 118045134
Publisher: The Lancet
Year: 2012
Tongue: English
Weight: 182 KB
Volume: 11
Category: Article
ISSN: 1474-4465
DOI: 10.1016/s1474-4422(12)70229-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Future of neuroprotection for acute stro

Future of neuroprotection for acute stroke: In the aftermath of the SAINT trials

✍ Sean I. Savitz; Marc Fisher 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 1 views

## Abstract The concept of neuroprotective therapy for acute ischemic stroke to salvage tissue at risk and improve functional outcome is based on sound scientific principles and extensive preclinical animal studies demonstrating efficacy. The failure of most neuroprotective drugs in clinical trials

Citicoline in pre-clinical animal models

Citicoline in pre-clinical animal models of stroke: a meta-analysis shows the optimal neuroprotective profile and the missing steps for jumping into a stroke clinical trial

✍ Alejandro Bustamante; Dolors Giralt; Lidia Garcia-Bonilla; Mireia Campos; Anna R 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 349 KB

The Neuroprotection with Statin Therapy

The Neuroprotection with Statin Therapy for Acute Recovery Trial (NeuSTART): an adaptive design phase I dose-escalation study of high-dose lovastatin in acute ischemic stroke

✍ Mitchell S. V. Elkind; Ralph L. Sacco; Robert B. MacArthur; Daniel J. Fink; Elli 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB